David Brewster

David W. Brewster

Vice President at Vertex Pharmaceuticals Incorporated

Location:
50 Northern Avenue, Boston, Massachusetts, United States
HQ Phone:
(617) 341-6100

General Information

Experience

Conference Co-Chair  - The Center for Business Intelligence

Vice President and Head, NonClinical Drug Safety  - F. Hoffmann-La Roche Ltd.

Research Specialist  - Monsanto Company

Education

American Board of Toxicology

BA  - Biology , University of Kentucky

Masters  - Toxicology , University of Kentucky

Ph.D.  - Environmental Toxicology/Entomology , Michigan State University

Affiliations

Executive Director  - Purdue Pharma

Director of Toxicology and Head US Projects  - Aventis SA

Recent News  

Dr. David Brewster, Vice President & Senior Safety Expert for Global Non-Clinical Safety, F. Hoffman-La Roche (Nutley, NJ)

Read More

David Brewster, Ph.D
Events David Brewster, Ph.D, Vice President, Nonclinical Safety, F. Hoffman-La Roche Dr. Brewster is Board certified toxicologist with over 25 years of research experience in toxicology and nearly 19 years experience in the pharmaceutical industry. He has extensive experience in the development of new molecular entities (small molecules), medical devices, large molecules, reformulations of marketed products and global product registration and support. He has built programs and rejuvenated programs. At Monsanto he developed and led the thyroid biochemical toxicology and cell proliferation programs. During his tenure at Aventis and its predecessor companies he built and staffed an investigative toxicology group and assumed increasing responsibilities up to the Director of Toxicology and Head of US projects. At Purdue he reorganized and re-energized the organization and integrated the toxicology, pathology, bioanalytical, drug metabolism and toxicokinetic groups into a high performing team. At Roche he is responsible for preclinical safety assessment at Roche Pharmaceuticals, Nutley NJ . where he has oversight of the toxicology, pathology, drug metabolism, bioanalytics, and pharmacokinetics/toxicokinetics groups and is responsible for setting policy and directing strategic planning for non-clinical safety testing.

Read More

Browse ZoomInfo’s Directories